AIP
ABBV icon

Ahrens Investment Partners’s AbbVie ABBV Stock Holding History

Ahrens Investment Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$2.18M Sell
13,675
-1,255
-8% -$192K 1.08% 23
2022
Q4 		$2.41M Sell
14,930
-923
-6% -$142K 1.1% 28
2022
Q3 		$2.13M Sell
15,853
-1,397
-8% -$200K 1.12% 25
2022
Q2 		$2.64M Sell
17,250
-5,662
-25% -$865K 1.17% 21
2022
Q1 		$3.71M Buy
22,912
+13,323
+139% +$1.94M 1.17% 25
2021
Q4 		$1.3M Buy
9,589
+705
+8% +$83.3K 0.57% 36
2021
Q3 		$958K Sell
8,884
-36
-0.4% -$4.11K 0.46% 60
2021
Q2 		$1M Buy
8,920
+100
+1% +$11.3K 0.46% 55
2021
Q1 		$955K Sell
8,820
-1,975
-18% -$211K 0.48% 59
2020
Q4 		$1.16M Buy
10,795
+1,516
+16% +$146K 0.62% 47
2020
Q3 		$813K Sell
9,279
-5,936
-39% -$559K 0.54% 47
2020
Q2 		$1.49M Buy
15,215
+11,921
+362% +$1.05M 0.91% 30
2020
Q1 		$251K Sell
3,294
-500
-13% -$42.6K 0.18% 93
2019
Q4 		$336K Buy
+3,794
New +$315K 0.14% 112
2019
Q1 		– Sell
-3,498
Closed -$322K – 171
2018
Q4 		$322K Buy
+3,498
New +$308K 0.15% 101
2018
Q2 		– Sell
-2,223
Closed -$210K – 169
2018
Q1 		$210K Sell
2,223
-507
-19% -$55.7K 0.09% 133
2017
Q4 		$264K Sell
2,730
-125
-4% -$11.8K 0.11% 124
2017
Q3 		$254K Sell
2,855
-352
-11% -$26.8K 0.11% 118
2017
Q2 		$219K Buy
3,207
+14
+0.4% +$941 0.09% 128
2017
Q1 		$208K Buy
+3,193
New +$201K 0.1% 123

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Ahrens Investment Partners's ABBV Position: Q1 2023 in Review

Ahrens Investment Partners reduced its AbbVie (ABBV) stake by 8.4% in Q1 2023, selling an estimated $192K and leaving 13,675 shares worth $2.18M. The position accounts for 1.08% of the portfolio, ranked #23.

Ahrens Investment Partners first reported a position in ABBV in Q1 2017 and has held it in 20 quarters since. The position peaked at $3.71M in Q1 2022. 3,139 funds tracked by Wall St. Rank hold ABBV as of Q1 2023.

  • Ahrens Investment Partners held 13,675 shares of AbbVie worth $2.18M as of Q1 2023.
  • Ahrens Investment Partners sold 1,255 AbbVie shares in Q1 2023, an estimated $192K.
  • AbbVie made up 1.08% of Ahrens Investment Partners's portfolio in Q1 2023, its #23 holding.
  • Ahrens Investment Partners first reported a position in AbbVie in Q1 2017 and has held it in 20 quarters since.
  • Ahrens Investment Partners's AbbVie position peaked at $3.71M in Q1 2022.
  • 3,139 funds tracked by Wall St. Rank held AbbVie as of Q1 2023.

Based on Ahrens Investment Partners's 13F filing for Q1 2023, filed 24 Apr 2023.